Edition:
United Kingdom

People: Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

21.50EUR
16 Sep 2019
Change (% chg)

€0.00 (+0.00%)
Prev Close
€21.50
Open
€21.80
Day's High
€21.90
Day's Low
€21.50
Volume
8,882
Avg. Vol
5,650
52-wk High
€28.90
52-wk Low
€18.00

Piat, Stephane 

Mr. Stephane Piat has been Chief Executive Officer and Director of Carmat SA since April 27, 2017. He was appointed as Chief Executive Officer as of August 29. 2016. He is currently also Director at Triflo Cardiovascular Inc. He started his career at Becton Dickinson European Headquarters as a Market Researcher in 1995. He was appointed European Platform Leader for Locoregional Anaesthesia five years later. In 2002, he joined Cordis, a Johnson & Johnson company, where he spent five years in several management positions ranging from Business Director France to European Marketing Director for Cardiology. In 2007, he moved to Abbott Vascular as General Manager for mid-size countries, EMEA, and two yearslater oversaw the integration of Evalve as the company’s General Manager EMEA, heading clinical and commercial development of a new interventional cardiology product, Mitraclip. In 2014, he led Global Market Development of the Abbott Vascular Structural Heart Division in San Francisco as Division Vice President. Mr Piat holds a master’s degree in Management Science from IAE Dijon, and a post-graduate degree in Quantitative Marketing from ESA business school in Grenoble (now IAE Grenoble).

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --